How Can High-Quality Treatments Become More Affordable? | The Next Frontier for Accessible Medicines
How Can High-Quality Treatments Become More Affordable? | The Next Frontier for Accessible Medicines
Featuring interviews with Senator Peter Welch of Vermont on the future of prescription-drug policy, and with IQVIA Institute for Human Data Science’s Murray Aitken and Apotex USA’s Christine Baeder on the impact of biosimilars in expanding access, moderated by AtlanticLIVE’s Jeanne Meserve. Join us for insights on how lawmakers and industry are navigating rising drug prices, patent reform, emerging health threats, and more.
#PeterWelch #Vermont #Senators #Prescription #drugprices #drugcosts #insurance #medicare #Medicaid #patentreform #Pharmaceuticals #pharma #pharmaceuticalindustry #healththreats #AffordableCare #healthcare #AccessibleCare #AAM #associationforaccessiblemedicines #biosimilarscouncil #TheAtlantic #AtlanticLive #atlanticevent
Sponsor Content: Goldman Sachs’ Asahi Pompey speaks to the impact of the firm’s 10,000 Small Businesses
Sponsor Content: Goldman Sachs’ Asahi Pompey speaks to the impact of the firm’s 10,000 Small Businesses education program at this year’s The Atlantic Festival.
Read more about the program: https://www.goldmansachs.com/citizenship/10000-small-businesses/US/
#TAF24
Eli Lilly and Company Presents: Reimagining Alzheimer’s Disease: Transformations in Care
In 2024, an estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s Disease (AD)1. This figure is expected to increase to 14 million by 2060 barring the availability of medical breakthroughs to slow or cure the disease. The past few years have seen significant progress with enhanced availability of detection and diagnosis tools and FDA approval of disease modifying medicines, offering a new hope for better aging. In a conversation facilitated by Lilly, Nicholas Thompson sits down with Anne White, Executive Vice President and President of Lilly Neuroscience of Eli Lilly and Company, to delve into the shifting paradigm of care and challenging our societal norms in how we view and approach the disease – and the people with it.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Eli Lilly and Company Presents: Reframing Views on Alzheimer’s | The Atlantic Festival 2024
By 2060, 14 million Americans aged 65 and older will be living with Alzheimer’s disease. With more diagnosis tools and approved treatments for those in the earliest stages of the disease, understanding the initial signs and symptoms of Alzheimer’s has never been more essential. Watch the conversation with experts and advocates with lived experience, providing an inside perspective into how to think about the differences in memory and thinking issues associated with normal aging, and those that could be a sign of something more serious.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Allstate Presents: Building Climate Resiliency: Adapting to a Changed Landscape
Research from Allstate and the U.S. Chamber of Commerce reveals a compelling statistic: every dollar invested in resilience and preparedness could save $13 in economic impact and damage costs post-disaster. Mitigating the effects of climate change is not enough. We need to adapt to an already changed landscape. This session will delve into the critical importance of climate adaptation strategies, exploring how communities, businesses, and governments can proactively prepare for and respond to the challenges posed by a rapidly changing climate. Join Allstate’s Justin Panther and The Atlantic Publisher Alice McKown to learn more.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Evernorth Health Services Presents: AI Concierges Tackle the Toughest Customer Yet—The U.S. Health-Care System
Paired with behavioral science, large language models and intelligent agents that interact with people unlock new opportunities for health care. Rather than forcing people to wrestle with the complexities of the U.S. health-care system, we can begin to reshape the system to better serve its users.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Visit Seattle Presents: How Seattle Fuels Free Expression Through Generations
Seattle author Jewell Parker Rhodes has had her book Ghost Boys banned in both California and Florida. Despite that, Rhodes has not only continued to write, she has inspired others to use their voices as well. In this session, she shares why she continues to write, how book bans impact future generations and why she believes Seattle, a UNESCO City of Literature, fosters freedom of expression, equity and inclusion across generations.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Calm Presents: The Myth of a Fix: Mental Health Isn’t a Problem to Solve
Mental health conditions are here to stay—and that’s okay. More than one third of adults will experience anxiety and depression symptoms in a given year, not accounting for the suspected underdiagnosis of these conditions. Today, mental health is evident in our classrooms, within our families, at the workplace and among our friends, but the focus remains on solving this crisis. Nicolas Thompson and David Ko, CEO of Calm, sit down to explore a refreshed perspective on managing—not solving—the mental health crisis in America and how digital tools and a new outlook can help turn the tide on mental health management.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Southern Company Presents: The Charge Toward Clean Energy
Southern Company Chairman, President and CEO, Chris Womack, sits down with Nicholas Thompson to explore the immense change the energy sector is experiencing and how Southern Company is meeting the growing energy needs of our nation and supporting communities in the transition to a clean energy future.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
W. K. Kellogg Foundation Presents: Democratizing AI for Our Children’s Future
Join the W. K. Kellogg Foundation’s Chief Transformation and Organizational Effectiveness Officer, Dr. Alandra L. Washington, for a candid look at issues around the inclusiveness of AI with Atlantic CEO Nick Thompson. This discussion will share a perspective on the current limitations of commercial AI systems and a future vision for making it a more equitable tool to create opportunities for all children. As WKKF identifies in its planning tool for what children will need in the next decade, “Lighting Up the Future for Children,” there is an urgent need to democratize the rapid pace of technological change and develop strategies for universal access to AI technologies.
Genentech Presents: Bias to Breakthroughs: Transforming Inclusive Clinical Research With AI
Can AI save lives by accelerating inclusive clinical research? In this session, top health-care professionals and tech experts explore the transformative potential of AI through an interactive live podcast recording and share their efforts to advance clinical research by expanding to underrepresented patients, minimizing perpetuating human biases and widening health-equity gaps.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
Goldman Sachs Presents: Fueling Small-Business Growth: Unlocking Potential Through Capital
Goldman Sachs 10,000 Small Businesses has helped entrepreneurs across the country grow their businesses for more than a decade by offering a free practical business-training program, access to capital, and personalized support services. In addition to serving more than 15,000 small-business owners through its education program, Goldman Sachs has deployed capital to Community Development Finance Institutions (CDFIs) to provide loans to more than 38,000 small businesses across the country. This session will bring together the expertise of Asahi Pompey, president of the Goldman Sachs Foundation, with a small-business graduate of Goldman Sachs 10,000 Small Businesses. Jessica Dehn is the owner of Explore Academy and a recipient of loan capital from MoFi, one of Goldman Sachs’s longest-standing CDFI partners. The discussion will focus on the importance of capital in enabling small businesses to grow, create jobs, and thrive in an ever-shifting landscape.
This session is produced by our underwriter and is independent of The Atlantic’s editorial staff.
